Visionary Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,357
Closed -$281K 553
2024
Q3
$281K Sell
2,357
-1,206
-34% -$161K 0.02% 445
2024
Q2
$509K Buy
3,563
+342
+11% +$45.3K 0.03% 324
2024
Q1
$414K Buy
3,221
+627
+24% +$74.6K 0.03% 355
2023
Q4
$268K Buy
2,594
+300
+13% +$29.7K 0.02% 411
2023
Q3
$209K Buy
+2,294
New +$202K 0.02% 421

Other funds holding NVO

Visionary Wealth Advisors's NVO Position: Q4 2024 in Review

Visionary Wealth Advisors sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,357 shares — an estimated $281K sold.

Visionary Wealth Advisors first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $509K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Visionary Wealth Advisors reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Visionary Wealth Advisors sold 2,357 Novo Nordisk shares in Q4 2024, an estimated $281K.
  • Visionary Wealth Advisors first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • Visionary Wealth Advisors's Novo Nordisk position peaked at $509K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Visionary Wealth Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.